- Agile Therapeutics (AGRX) -16%.
- Bed Bath & Beyond (BBBY) -13% on Q1 earnings release.
- Barnes & Noble Education (BNED) -15% on Q4 earnings release.
- Himax Technologies (HIMX) -12%.
- AeroVironment (AVAV) -12% on Q4 earnings release.
- Benitec Biopharma (BNTC) -10%.
- Wejo Group (WEJO) -10%.
- Evofem Biosciences (EVFM) -10%.
- Graybug Vision (GRAY) -10%.
- Upstart Holdings (UPST) -9% as it was downgraded to Underweight at Morgan Stanley as rates rise.
- Acutus Medical (AFIB) -9%.
- ASE Technology Holding (ASX) -9%.
- Carnival Corporation (CUK) -8%.
- Grifols (GRFS) -8%.
- Revlon (REV) -8% as shorts increase bets against the stock.
- ToughBuilt Industries (TBLT) -8%.
- Moving iMage Technologies (MITQ) -8%.
- Visionary Education Technology Holdings (VEDU) -6%.
- Femasys (FEMY) -6%.
- Array Technologies (ARRY) -5%.
- NIO (NIO) -6% after NIO calls Grizzly report erroneous, without merit.
- Fujian Blue Hat Interactive Entertainment Technology (BHAT) -6%.
- 89bio (ETNB) -6% on pricing upsized $$94.5M in stock and pre-funded warrants offering.
- McCormick & Company (MKC) -6% after misses Q2 expectation, cuts FY2022 outlook.